Prospective follow-up of a cohort of preterm infants < 33 WG receiving ketamine for tracheal intubation in the delivery room: Neurological outcome at 1 and 2 years

This prospective cohort of 51 preterm newborns having received ketamine at birth did not reveal any differences in terms of neurological development at the age of 2 (relative to a control group and the literature data). These preliminary results must be confirmed in a randomized trial with longer follow-up.